Corestate Capital (CCAP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Aug, 2025Executive summary
Completed major financial and operational restructuring, shifting to a holding structure with focus on asset divestment and core real estate management.
Strategic objectives: maximize value from non-core asset sales to service debt and grow Hannover Leasing and STAM France as independent platforms.
Nearly all planned restructuring measures implemented by year-end 2024, with only minor costs expected in 2025.
Financial highlights
Aggregated revenue and gains for FY 2024 were €37.3 million, down from €287.7 million in FY 2023 (adjusted).
EBITDA for FY 2024 was €-26.5 million; adjusted EBITDA was €-7.0 million, reflecting restructuring and valuation effects.
Net profit for FY 2024 was €-57.7 million, including asset write-downs, D&A, bond interest, and an extraordinary tax payment.
Adjusted net profit stood at €-31.9 million; EPS at €-0.3; equity ratio declined to 12.0%.
Cash and cash equivalents at year-end were €30.6 million; net debt increased to €187.2 million.
Outlook and guidance
From 2025, all net proceeds from asset sales will be used for interest and principal payments on outstanding notes.
Asset sales in 2025 expected to generate €72 million, enabling full repayment of Super Senior Note and PIK interest by year-end 2025.
First repayments of Senior Notes anticipated in 2025; focus remains on deleveraging and profitable growth in core business.
Latest events from Corestate Capital
- Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 20255 Jan 2026 - Revenue and EBITDA fell, but asset sales and liquidity support ongoing deleveraging.CCAP
Q2 20255 Sep 2025 - Revenue up, profits down; asset sales and debt repayment drive 2025 strategy.CCAP
Q1 202517 Jun 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 202413 Jun 2025 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 202413 Jun 2025 - Losses narrowed and asset sales progressed, but liquidity remains a key challenge.CCAP
Q1 202413 Jun 2025